相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bariatric Surgery and Osteoporosis
Julien Paccou et al.
CALCIFIED TISSUE INTERNATIONAL (2022)
Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response
Xin Cui et al.
BRAIN RESEARCH BULLETIN (2021)
Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis
Ahmed El-Gazzar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
RANKL as the master regulator of osteoclast differentiation
Hiroshi Takayanagi
JOURNAL OF BONE AND MINERAL METABOLISM (2021)
Testosterone and Bone Health in Men: A Narrative Review
Kazuyoshi Shigehara et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Trem2 mediated Syk-dependent ROS amplification is essential for osteoclastogenesis in periodontitis microenvironment
Yuteng Weng et al.
REDOX BIOLOGY (2021)
Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells
Dixcy Jaba Sheeba John Mary et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
Yeon-Suk Yang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
Ji-Yoon Noh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis
Laura Gambari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways
Yan Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions
Maria-Bernadette Madel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways
Ziqing Yin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway
Xiao Lin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Update on Menopausal Hormone Therapy for Fracture Prevention
Jan J. Stepan et al.
CURRENT OSTEOPOROSIS REPORTS (2019)
Combination therapies in the treatment of osteoporosis
Jennifer J. Kelly et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2019)
From macrophage to osteoclast - How metabolism determines function and activity
Katharina F. Kubatzky et al.
CYTOKINE (2018)
The Sealing Zone in Osteoclasts: A Self-Organized Structure on the Bone
Jiro Takito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The biology of normal bone remodelling
P. Katsimbri
EUROPEAN JOURNAL OF CANCER CARE (2017)
DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis
Xiaofeng Cai et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
TREM2/DAP12 Complex Regulates Inflammatory Responses in Microglia via the JNK Signaling Pathway
Li Zhong et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts
Mary Beth Humphrey et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Identification of crucial genes related to postmenopausal osteoporosis using gene expression profiling
Min Ma et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2016)
DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis
Yan Zhang et al.
SCIENCE SIGNALING (2015)
Inhibiting actin depolymerization enhances osteoblast differentiation and bone formation in human stromal stem cells
Li Chen et al.
STEM CELL RESEARCH (2015)
DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis
Yan Zhang et al.
SCIENCE SIGNALING (2015)
The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women
Barry S. Komm et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)
Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12
Agnieszka Paradowska-Gorycka et al.
HUMAN IMMUNOLOGY (2013)
Changes in Bone Resorption Across the Menopause Transition: Effects of Reproductive Hormones, Body Size, and Ethnicity
MaryFran R. Sowers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
DAP12 Overexpression Induces Osteopenia and Impaired Early Hematopoiesis
Genevieve Despars et al.
PLOS ONE (2013)
Mutations in CSTA, Encoding Cystatin A, Underlie Exfoliative Ichthyosis and Reveal a Role for This Protease Inhibitor in Cell-Cell Adhesion
Diana C. Blaydon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation
Takako Negishi-Koga et al.
IMMUNOLOGICAL REVIEWS (2009)
TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function
MB Humphrey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase
A Mócsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Impaired differentiation of osteoclasts in TREM-2-deficient individuals
M Cella et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
J Paloneva et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype
J Paloneva et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
分享论文
